The In2Sight Consortium held yesterday the First Review Meeting with experts from the European Innovation Council and SMEs Executive Agency (EISMEA), to follow-up on the project progress from the first year and to hear valuable recommendations from the experts.
The goal of the project is to foster an unprecedented breakthrough in in-vivo optical imaging that will radically renew the biocompatibility tests of biomaterials.
The project is progressing and the first interesting results are starting to be published. Stay tuned for the next updates!
Check the project website for further information about In2Sight:
You can also contact us at: info@asphalion.com
